Skip to main content
DLB logo

DLB · Dolby Laboratories, Inc.

Track DLB — free
Market Cap
$5.76B
Shares
93.67M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Kevin Yeaman $10,193,397
John Couling $4,130,882
Andy Sherman $4,044,164
Shriram Revankar $3,688,289
Robert Park $3,620,627
Fiscal 2024
Executive Total
Kevin Yeaman $9,678,964
John Couling $3,847,523
Andy Sherman $3,756,577
Shriram Revankar $3,625,715
Robert Park $3,348,158
Fiscal 2023
Executive Total
Kevin Yeaman $9,504,201
John Couling $3,896,127
Andy Sherman $3,509,190
Robert Park $3,291,806
Todd Pendleton $3,188,239
Shriram Revankar $2,360,974
Fiscal 2022
Executive Total
Kevin Yeaman $9,407,217
Shriram Revankar $5,449,178
Robert Park $4,948,662
John Couling $3,847,629
Andy Sherman $3,440,169
Todd Pendleton $3,106,026
Fiscal 2021
Executive Total
Kevin Yeaman $9,629,118
Andy Sherman $3,527,315
Todd Pendleton $3,225,122

Executive changes

Person Change Filed
Kevin Yeaman Retired 2026-08-27
Kevin Yeaman Retired 2026-08-27
Marc Whitten Appointed 2026-08-27
Marc Whitten Appointed 2026-08-27
Avadis Tevanian, Jr. Appointed 2023-02-10
Anjali Sud Appointed 2023-02-10
Emily Rollins Appointed 2023-02-10
Simon Segars Appointed 2023-02-10
Tony Prophet Appointed 2023-02-10
David Dolby Appointed 2023-02-10
Micheline Chau Appointed 2023-02-10
Peter Gotcher Appointed 2023-02-10
Kevin Yeaman Appointed 2023-02-10
Tony Prophet Appointed 2021-12-08
Robert J. Park Appointed 2021-10-15
Emily Rollins Appointed 2021-02-25
Anjali Sud Appointed 2020-02-07
Avadis Tevanian, Jr. Appointed 2020-02-07
N. William Jasper, Jr. Appointed 2020-02-07
Simon Segars Appointed 2020-02-07
Roger Siboni Appointed 2020-02-07
David Dolby Appointed 2020-02-07
Peter Gotcher Appointed 2020-02-07
Micheline Chau Appointed 2020-02-07
Kevin Yeaman Appointed 2020-02-07
Key facts CIK 1308547 CUSIP 25659T107 13F (30d) 292 filings 282 filers Visit website Investor relations